AstraZeneca vaccine non-certification by EMA may hamper entry of Brazilians into Europe

The European Medicines Agency (EMA) has not included Covishield, AstraZeneca's immunizer manufactured in India, in the list of approved vaccines for its digital certificate for travelers.

RIO DE JANEIRO, BRAZIL - The decision of the European Medicines Agency (EMA) not to include Covishield, AstraZeneca's version of the vaccine manufactured in India, in a list of immunizers approved for its digital certificate for travelers, has caused doubts regarding the entry into the European Union of citizens from countries outside the block.

Brazil's Fiocruz received 4 million ready doses of Covishield among the 66 million doses of the AstraZeneca immunizer - which would expose citizens of Brazil to difficulties when traveling to Europe.

On Tuesday, June 29, when the agency announced the decision due to differences between Covishield . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?